Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome

Impaired lung function, either with airflow limitation or with preserved ratio impaired spirometry (PRISm), is common globally and associated with increased cardiorespiratory morbidity, cause-specific mortality and overall mortality.1,2 In this context, understanding the impact of metabolic syndrome...

Full description

Bibliographic Details
Main Authors: Sadeghimakki, Roham, Tahrani, Abd A.
Format: Article
Language:English
Published: Elsevier 2023
Subjects:
Online Access:https://repository.londonmet.ac.uk/8982/1/1-s2.0-S2666776223002156-main.pdf
_version_ 1804072962383413248
author Sadeghimakki, Roham
Tahrani, Abd A.
author_facet Sadeghimakki, Roham
Tahrani, Abd A.
author_sort Sadeghimakki, Roham
collection LMU
description Impaired lung function, either with airflow limitation or with preserved ratio impaired spirometry (PRISm), is common globally and associated with increased cardiorespiratory morbidity, cause-specific mortality and overall mortality.1,2 In this context, understanding the impact of metabolic syndrome on cardiopulmonary outcomes is clinically important, given the growing global prevalence of metabolic syndrome, driven in part by the increasing obesity rates, and its associations with major adverse cardiovascular events and all-cause mortality.
first_indexed 2024-07-09T04:07:29Z
format Article
id oai:repository.londonmet.ac.uk:8982
institution London Metropolitan University
language English
last_indexed 2024-07-09T04:07:29Z
publishDate 2023
publisher Elsevier
record_format eprints
spelling oai:repository.londonmet.ac.uk:89822024-01-04T14:43:12Z http://repository.londonmet.ac.uk/8982/ Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome Sadeghimakki, Roham Tahrani, Abd A. 610 Medicine & health Impaired lung function, either with airflow limitation or with preserved ratio impaired spirometry (PRISm), is common globally and associated with increased cardiorespiratory morbidity, cause-specific mortality and overall mortality.1,2 In this context, understanding the impact of metabolic syndrome on cardiopulmonary outcomes is clinically important, given the growing global prevalence of metabolic syndrome, driven in part by the increasing obesity rates, and its associations with major adverse cardiovascular events and all-cause mortality. Elsevier 2023-12 Article PeerReviewed text en cc_by_nc_nd_4 https://repository.londonmet.ac.uk/8982/1/1-s2.0-S2666776223002156-main.pdf Sadeghimakki, Roham and Tahrani, Abd A. (2023) Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome. The Lancet regional health. Europe, 35 (100796). pp. 1-2. ISSN 2666-7762 https://doi.org/10.1016/j.lanepe.2023.100796 10.1016/j.lanepe.2023.100796
spellingShingle 610 Medicine & health
Sadeghimakki, Roham
Tahrani, Abd A.
Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome
title Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome
title_full Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome
title_fullStr Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome
title_full_unstemmed Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome
title_short Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome
title_sort cardiopulmonary outcomes in people with impaired lung function the role of metabolic syndrome
topic 610 Medicine & health
url https://repository.londonmet.ac.uk/8982/1/1-s2.0-S2666776223002156-main.pdf
work_keys_str_mv AT sadeghimakkiroham cardiopulmonaryoutcomesinpeoplewithimpairedlungfunctiontheroleofmetabolicsyndrome
AT tahraniabda cardiopulmonaryoutcomesinpeoplewithimpairedlungfunctiontheroleofmetabolicsyndrome